Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03067948 · ClinicalTrials.gov registry record · NA

Improving Identification of Mental Health/Substance Use Disorders in HIV Primary Care: Pilot Clinical Response

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
32
Enrollment target

NCT03067948: Completed NA study, sponsored by Johns Hopkins University.

NCT03067948 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03067948, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

This research is a feasibility pilot of an intervention to respond to positive screening tests for mental health(MH) and substance use (SU) captured through the Patient Reported Outcomes questionnaires (PROs). The PROs are currently performed in the clinic, however, the results are neither reviewed with patients nor transmitted to providers. This pilot assesses the feasibility of moving the PROs into the clinical realm by having patients review the PRO results, identifying an issue to discuss at the patient's next HIV primary care visit, and determining whether this process increases discussion of MH and SU disorders in the subsequent clinical visit and/or increases referrals to MH and/or SU treatment.

Primary Outcome

Number of participants for whom review and coding of audio recording captured a mental health or substance use issue during their visit

Interventions

  • BEHAVIORAL Patient Designated Positive Screen Shared with Provider

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2017-02-09
Est. Completion 2017-07-31
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT03067948 record still lists

NCT03067948 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient Designated Positive Screen Shared with Provider is the first listed.

NCT03067948 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03067948 about?

NCT03067948 is a clinical study titled "Improving Identification of Mental Health/Substance Use Disorders in HIV Primary Care: Pilot Clinical Response". This research is a feasibility pilot of an intervention to respond to positive screening tests for mental health(MH) and substance use (SU) captured through the Patient Reported Outcomes questionnaires (PROs). The PROs are currently performed in the clinic, however, the results are neither reviewed ...

What is the current status of trial NCT03067948?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2017-02-09. Estimated completion is 2017-07-31.

What interventions are being tested in trial NCT03067948?

The interventions under investigation include: Patient Designated Positive Screen Shared with Provider (BEHAVIORAL).

Who is sponsoring clinical trial NCT03067948?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03067948's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03067948, the US trial registry maintained by the National Library of Medicine. NCT03067948 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.